Shikonin differentially regulates glucose metabolism via PKM2 and HIF1α to overcome apoptosis in a refractory HCC cell line
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Shikonin differentially regulates glucose metabolism via PKM2 and HIF1α to overcome apoptosis in a refractory HCC cell line
Authors
Keywords
Shikonin, PKM2, HIF1α, Glycolysis, Mitochondrial biogenesis, Apoptosis
Journal
LIFE SCIENCES
Volume 265, Issue -, Pages 118796
Publisher
Elsevier BV
Online
2020-11-19
DOI
10.1016/j.lfs.2020.118796
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- PGC1α suppresses metastasis of HCC by inhibiting Warburg effect via PPARγ‐dependent WNT/β‐catenin/PDK1 axis
- (2020) Qiaozhu Zuo et al. HEPATOLOGY
- Succinylation-dependent mitochondrial translocation of PKM2 promotes cell survival in response to nutritional stress
- (2019) Hailong Qi et al. Cell Death & Disease
- Hypoxia/pseudohypoxia‐mediated activation of hypoxia‐inducible factor‐1α in cancer
- (2019) Yoshihiro Hayashi et al. CANCER SCIENCE
- PKM2 is the target of proanthocyanidin B2 during the inhibition of hepatocellular carcinoma
- (2019) Jiao Feng et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Shikonin inhibits triple-negative breast cancer-cell metastasis by reversing the epithelial-to-mesenchymal transition via glycogen synthase kinase 3β-regulated suppression of β-catenin signaling
- (2019) Yan Chen et al. BIOCHEMICAL PHARMACOLOGY
- MLKL contributes to shikonin-induced glioma cell necroptosis via promotion of chromatinolysis
- (2019) Ye Ding et al. CANCER LETTERS
- Direct impact of cisplatin on mitochondria induces ROS production that dictates cell fate of ovarian cancer cells
- (2019) Markus Kleih et al. Cell Death & Disease
- Circadian clock gene NPAS2 promotes reprogramming of glucose metabolism in hepatocellular carcinoma cells
- (2019) Peng Yuan et al. CANCER LETTERS
- The Role of Sirtuins in Antioxidant and Redox Signaling
- (2018) Chandra K. Singh et al. ANTIOXIDANTS & REDOX SIGNALING
- Metabolic reprogramming enables hepatocarcinoma cells to efficiently adapt and survive to a nutrient-restricted microenvironment
- (2018) Shamir Cassim et al. CELL CYCLE
- How the Warburg effect supports aggressiveness and drug resistance of cancer cells?
- (2018) Philippe Icard et al. DRUG RESISTANCE UPDATES
- Hexokinase-2 depletion inhibits glycolysis and induces oxidative phosphorylation in hepatocellular carcinoma and sensitizes to metformin
- (2018) Dannielle DeWaal et al. Nature Communications
- Aberrant Metabolism in Hepatocellular Carcinoma Provides Diagnostic and Therapeutic Opportunities
- (2018) Serena De Matteis et al. Oxidative Medicine and Cellular Longevity
- Reactive oxygen species (ROS) are a key determinant of cancer's metabolic phenotype
- (2017) Stefan Rodic et al. INTERNATIONAL JOURNAL OF CANCER
- Chrysin inhibited tumor glycolysis and induced apoptosis in hepatocellular carcinoma by targeting hexokinase-2
- (2017) Dong Xu et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- HSP90 promotes cell glycolysis, proliferation and inhibits apoptosis by regulating PKM2 abundance via Thr-328 phosphorylation in hepatocellular carcinoma
- (2017) Qiuran Xu et al. Molecular Cancer
- Mitochondrial PKM2 regulates oxidative stress-induced apoptosis by stabilizing Bcl2
- (2016) Ji Liang et al. CELL RESEARCH
- PARP Inhibition Suppresses Growth of EGFR-Mutant Cancers by Targeting Nuclear PKM2
- (2016) Nan Li et al. Cell Reports
- Shikonin induces mitochondria-mediated apoptosis and enhances chemotherapeutic sensitivity of gastric cancer through reactive oxygen species
- (2016) Wenquan Liang et al. Scientific Reports
- PARP14 promotes the Warburg effect in hepatocellular carcinoma by inhibiting JNK1-dependent PKM2 phosphorylation and activation
- (2015) Valeria Iansante et al. Nature Communications
- Aberrant IDH3α expression promotes malignant tumor growth by inducing HIF-1-mediated metabolic reprogramming and angiogenesis
- (2014) L Zeng et al. ONCOGENE
- The pentose phosphate pathway and cancer
- (2014) Krushna C. Patra et al. TRENDS IN BIOCHEMICAL SCIENCES
- JMJD5 regulates PKM2 nuclear translocation and reprograms HIF-1 -mediated glucose metabolism
- (2013) H.-J. Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- HIF1α Modulates Cell Fate Reprogramming Through Early Glycolytic Shift and Upregulation of PDK1-3 and PKM2
- (2013) Alessandro Prigione et al. STEM CELLS
- SIRT3 Opposes Reprogramming of Cancer Cell Metabolism through HIF1α Destabilization
- (2011) Lydia W.S. Finley et al. CANCER CELL
- Intracellular ATP Levels Are a Pivotal Determinant of Chemoresistance in Colon Cancer Cells
- (2011) Y. Zhou et al. CANCER RESEARCH
- Pyruvate Kinase M2 Is a PHD3-Stimulated Coactivator for Hypoxia-Inducible Factor 1
- (2011) Weibo Luo et al. CELL
- Shikonin and its analogs inhibit cancer cell glycolysis by targeting tumor pyruvate kinase-M2
- (2011) J Chen et al. ONCOGENE
- Nuclear Control of Respiratory Chain Expression by Nuclear Respiratory Factors and PGC-1-Related Coactivator
- (2010) Richard C. Scarpulla Annals of the New York Academy of Sciences
- SIRT3 Is a Mitochondria-Localized Tumor Suppressor Required for Maintenance of Mitochondrial Integrity and Metabolism during Stress
- (2010) Hyun-Seok Kim et al. CANCER CELL
- GLUT1 Expression Is Increased in Hepatocellular Carcinoma and Promotes Tumorigenesis
- (2009) Thomas Amann et al. AMERICAN JOURNAL OF PATHOLOGY
- A chemical genomics screen highlights the essential role of mitochondria in HIF-1 regulation
- (2008) X. Lin et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now